Yeung Danny Sheng Wu
Known title: Chief Executive OfficerCIK: 0001930070
Yeung Danny Sheng Wu's purchase track record
Yeung Danny Sheng Wu has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/20/2026 | PRE | $502K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PRE | ▲ Buy | Open Market | 6,000 | $125K | 8/24/2026 | View on chart |
| PRE | ▲ Buy | Open Market | 11,181 | $239K | 8/24/2026 | View on chart |
| PRE | ▲ Buy | Option Exercise | 53,953 | $5 | 8/20/2026 | View on chart |
| PRE | ▼ Sell | Other | 49,912 | $0 | 8/20/2026 | View on chart |
| PRE | ▲ Buy | Open Market | 7,500 | $137K | 8/20/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Prenetics Global Releases Q2 2026 Earnings Call Transcript
Prenetics Global has published the full transcript of its Q2 2026 earnings call. The transcript provides details on the company’s financial performance, guidance, and strategic initiatives. Investors can review the discussion to better understand the company’s outlook. The release follows the company’s recent earnings announcement.
Prenetics Global Releases Q2 2026 Earnings Call Transcript. Prenetics Global has published the full transcript of its Q2 2026 earnings call. The transcript provides details on the company’s financial performance, guidance, and strategic initiatives. Investors can review the discussion to better understand the company’s outlook. The release follows the company’s recent earnings announcement.